Alloimmunity does not protect from challenge with the feline immunodeficiency virus (Q45395136)

14 December 2017

Alloimmunity does not protect from challenge with the feline immunodeficiency virus (English)

1 reference

feline immunodeficiency virus

14 December 2017

object named as

feline immunodeficiency virus

1 reference

F Reggeti

1

1 reference

PubMed ID

18471896

14 December 2017

D Bienzle

series ordinal

2

1 reference

14 December 2017

30 March 2008

1 reference

Veterinary Immunology and Immunopathology

14 December 2017

1 reference

14 December 2017

124

1 reference

14 December 2017

1-2

1 reference

14 December 2017

152-162

1 reference

Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines

14 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Immunophenotype and functional properties of feline dendritic cells derived from blood and bone marrow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Vaccination with fixed feline immunodeficiency virus (FIV) infected cells: protection, breakthrough and specificity of response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Protection against FIV challenge infection by genetic vaccination using minimalistic DNA constructs for FIV env gene and feline IL-12 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

A novel virus capture assay reveals a differential acquisition of host HLA-DR by clinical isolates of human immunodeficiency virus type 1 expanded in primary human cells depending on the nature of producing cells and the donor source

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

HIV/AIDS. Vaccine results lose significance under scrutiny

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Public health. AIDS vaccine trial produces disappointment and confusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Dendritic cells, new tools for vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Attempt to modify the immune response developed against FIV gp120 protein by preliminary FIV DNA injection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Lessons from the cat: development of vaccines against lentiviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Limited efficacy of an inactivated feline immunodeficiency virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Targeted lymph node immunization can protect cats from a mucosal challenge with feline immunodeficiency virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Factors influencing cellular immune responses to feline immunodeficiency virus induced by DNA vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Enhancing antibodies in HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

The development of a vaccine against feline immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Enhancement after feline immunodeficiency virus vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Nonrandom association of cellular antigens with HTLV-III virions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Feline immunodeficiency virus subunit vaccines that induce virus neutralising antibodies but no protection against challenge infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Variable expression of major histocompatibility complex class II in the domestic cat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challenge infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Accelerated viraemia in cats vaccinated with fixed autologous FIV-infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

The ability of certain SIV vaccines to provoke reactions against normal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Vaccination against the feline immunodeficiency virus: the road not taken

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Partial protection by vaccination with recombinant feline immunodeficiency virus surface glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

AIDS vaccination studies using feline immunodeficiency virus as a model: immunisation with inactivated whole virus suppresses viraemia levels following intravaginal challenge with infected cells but not following intravenous challenge with cell-free

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Immunogenicity of an anti-clade B feline immunodeficiency fixed-cell virus vaccine in field cats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

The interaction of HIV with dendritic cells: outcomes and pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: protection from an intraclade challenge administered systemically or mucosally by an attenuated vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

MHC-restricted protection of cats against FIV infection by adoptive transfer of immune cells from FIV-vaccinated donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

CD134 and CXCR4 expression corresponds to feline immunodeficiency virus infection of lymphocytes, macrophages and dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Feline immunodeficiency virus subtypes A, B and C and intersubtype recombinants in Ontario, Canada.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Distribution of MHC class II antigens in feline tissues and peripheral blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Presence of class II histocompatibility DR proteins on the envelope of human immunodeficiency virus demonstrated by FACS analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Use of CD134 as a primary receptor by the feline immunodeficiency virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Autologous transplantation of retrovirally transduced bone marrow or neonatal blood cells into cats can lead to long-term engraftment in the absence of myeloablation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

The control of immunity and tolerance by dendritic cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Mucosal infection and vaccination against feline immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Anti-cell antibody in macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Nucleotide sequence and genomic organization of feline immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Vaccination against feline immunodeficiency virus using fixed infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Immune control of HIV: the obstacles of HLA and viral diversity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Complement-Mediated Enhancement of HIV-1 Neutralisation by Anti-HLA Antibodies Derived from Polytransfused Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Genetic characterization of FLA, the cat major histocompatibility complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Experimental vaccine protection against feline immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Comparative Genome Organization of Human, Murine, and Feline MHC Class II Region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

Direct identification of class II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.03.010

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VETIMM.2008.03.010

1 reference

release_bjm5ut7xxvgg5hmp4z7we44aza

14 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bjm5ut7xxvgg5hmp4z7we44aza

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

18471896

1 reference

PubMed ID

18471896